Oral steroid for cold-related wheezing in children under 2
Part of Lungs & breathing clinical trials.
This trial tests whether a short course of oral prednisolone (an anti-inflammatory steroid) helps young children under 2 who have wheezing triggered by a rhinovirus cold. It aims to see if steroid treatment can improve symptoms after an emergency visit.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child is under 2 years old
- A doctor has diagnosed wheezing or bronchitis (wheezing in the chest)
- In the emergency room, your child needed salbutamol (a rescue inhaler/medicine for wheeze)
- A quick swab test shows rhinovirus or picornavirus causing the cold
- Your child does not need emergency life-saving treatment right now
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses video recordings to see how well salbutamol helps children with wheezing caused by a virus. Researchers want to understand when this medicine works best.
This trial studies whether an early steroid treatment can lower the chance that children will go on to develop asthma after their first severe “wheezing” episode caused by a rhinovirus (a common cold virus). If you qualify, the goal is to prevent future asthma rather than just treat the current episode.
This study tests if giving oral steroids (medicine to reduce airway swelling) only when needed based on a child's own biology can help preschool children with wheezing. It aims to find the best treatment for each child, avoiding unnecessary medicine.
This trial tests whether a nebulized (inhaled) steroid called fluticasone propionate is safe and effective for infants 0–24 months old who are hospitalized for wheezing. It aims to reduce symptoms like wheezing and coughing.
This trial tests a medication called peginterferon to treat RSV bronchiolitis (a lung infection causing wheezing and breathing trouble) in children ages 6 months to 2 years. It aims to see if the drug helps them recover faster.
This study looks at young children (ages 1-5) who have had severe wheezing episodes that needed hospital care. It aims to find biomarkers (clues in the body) that could help predict which children might develop asthma later.
Hear when a new Bronchiolitis Acute Viral trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.